Journal of Affective Disorders 1992: Vol 24 Index

7 Pages·1992·1.2 MB·English

Author Index
Amsterdam, J.D. and Mozley, P.D. Endicott, J., see Coryell, W. (24) 93
Temporal lobe asymmetry with iofetamine (IMP) SPECT
imaging in patients with major depression (24) 43 Falkowski, J., see Birtchnell, J. (24) 165
Fava, E., see Lora, A. (24) 227
Beasley, Jr., C.M., Potvin, J.H., Masica, D.N., Wheadon, D.E., Feuillade, P., Pringuey, D., Belugou, J.L., Robert, P. and
Dornseif, B.E. and Genduso, L.A. Darcourt, G.
Fluoxetine: no association with suicidality in obsessive- Trimipramine: Acute and lasting effects on sleep in healthy
compulsive disorder (24) 1 and major depressive subjects (24) 135
Beersma, D.G.M. and Van den Hoofdakker, R.H. Fieve, R.R., see Peselow, E.D. (24) 209
Can non-REM sleep be depressogenic? (24) 101 Frances, A.J., see Markowitz, J.C. (24) 63
Belugou, J.L., see Feuillade, P. (24) 135
Birtchnell, J., Falkowski, J. and Steffert, B. Gangadhar, B.N., see Jagadeesh, H.N. (24) 291
The negative relating of depressed patients: a new ap- Gasté, C., see Vieta, E. (24) 147
proach (24) 165 Genduso, L.A., see Beasley, Jr., C.M. (24) 1
Bouman, T.K., De Vries, J. and Koopmans, I.H. Gupta, N., see Khanna, R. (24) 35
Lithium prophylaxis and interepisode mood. A prospective
Hadzi-Pavlovic, D., see Parker, G. (24) 17
longitudinal comparison of euthymic bipolars and non-pa-
Hadzi-Paviovic, D., see Parker, G. (24) 25
tient controls (24) 199
Hallstrom, C., see Tattersall, M.L. (24) 193
Boyce, P., see Parker, G. (24) 25
Heun, R., see Maier, W. (24) 153
Bridts, C.H., see Maes, M. (24) 127
Hickie, I., see Parker, G. (24) 25
Brodaty, H., see Parker, G. (24) 25
Holton, A., Riley, P. and Tyrer, P.
Buchanan, A., see Lam, R.W. (24) 237
Factors predicting long-term outcome after chronic benzo-
diazepine therapy (24) 245
Chan, D.W.
Coping with depressed mood among Chinese medical stu- Jagadeesh, H.N., Gangadhar, B.N., Janakiramaiah, N., Sub-
dents in Hong Kong (24) 109 bakrishna, D.K. and Jain, S.
Checkley, S.A., see Marks, M.N. (24) 253 Time dependent therapeutic effects of single electrocon-
Chen, C.-N., see Lee, S. (24) 265 vulsive therapy (ECT) in endogenous depression (24) 291
Chow, C.C., see Lee, S. (24) 265 Jain, S., see Jagadeesh, H.N. (24) 291
Cirera, E., see Vieta, E. (24) 147 Janakiramaiah, N., see Jagadeesh, H.N. (24) 291
Cloninger, C.R., see Svrakic, D.M. (24) 217 Joyce, P.R., see Wilson, D.A. (24) 11
Cooreman, W., see Maes, M. (24) 183
Corral, M.R., see Lam, R.W. (24) 237 Keller, M., see Coryell, W. (24) 93
Coryell, W., Winokur, G., Keller, M., Scheftner, W. and Kellner, R., see Starcevic, V. (24) 73
Endicott, J. Khanna, R., Gupta, N. and Shanker, S.
Alcoholism and primary major depression: a family study Course of bipolar disorder in eastern India (24) 35
approach to co-existing disorders (24) 93 Kocsis, J.H., see Markowitz, J.C. (24) 63
Cosyns, P., see Maes, M. (24) 127 Koeter, M.W.J.
Cosyns, P., see Maes, M. (24) 183 Validity of the GHQ and SCL anxiety and depression
Cowen, P.J., see Da Roza Davis, J.M. (24) 177 scales: A comparative study (24) 271
Koopmans, I.H., see Bouman, T.K. (24) 199
Darcourt, G., see Feuillade, P. (24) 135 Kumar, R., see Marks, M.N. (24) 253
Da Roza Davis, J.M., Sharpley, A.L., Solomon, R.A. and
Cowen, P.J. Lam, R.W., Buchanan, A., Mador, J.A., Corral, M.R. and
Sleep and 5-HT, receptor sensitivity in recovered de- Remick, R.A.
pressed patients (24) 177 The effects of ultraviolet-A wavelengths in light therapy
DeClerck, L.S., see Maes, M. (24) 127 for seasonal depression (24) 237
De Vries, J., see Bouman, T.K. (24) 199 Lee, S., Chow, C.C., Shek, C.C., Wing, Y.K. and Chen, C.-N.
DiFiglia, C., see Peselow, E.D. (24) 209 Folate concentration in chinese psychiatric outpatients on
Dornseif, B.E.,-see Beasley, Jr., C.M. (24) 1 long-term lithium treatment (24) 265
300
Lichtermann, D., see Maier, W. (24) 153 endogenous depression. Clinical, therapeutic, and biologi-
Lora, A. and Fava, E. cal correlations (24) 55
Provoking agents, vulnerability factors and depression in
an Italian setting: a replication of Brown and Harris's Remick, R.A., see Lam, R.W. (24) 237
model (24) 227 Riley, P., see Holton, A. (24) 245
Robert, P., see Feuillade, P. (24) 135
Mador, J.A., see Lam, R.W. (24) 237 Roy, K., see Parker, G. (24) 17
Maes, M., Scharpé, S., Van Grootel, L., Uyttenbroeck, W., Rybakowski, J. and Plocka, M.
Cooreman, W., Cosyns, P. and Suy, E. Seasonal variations of the dexamethasone suppression test
Higher a,-antitrypsin, haptoglobin, ceruloplasmin and in depression compared with schizophrenia: a gender ef-
lower retinol binding protein plasma levels during depres- fect (24) 87
sion: further evidence for the existence of an inflammatory
response during that illness (24) 183 Scharpé, S., see Maes, M. (24) 183
Maes, M., Stevens, W.J., DeClerck, L.S., Bridts, C.H., Peeters, Scheftner, W., see Coryell, W. (24) 93
D., Schotte, C. and Cosyns, P. Schotte, C., see Maes, M. (24) 127
A significantly increased number and percentage of B cells Shanker, S., see Khanna, R. (24) 35
in depressed subjects: results of flow cytometric measure- Sharpley, A.L., see Da Roza Davis, J.M. (24) 177
ments (24) 127 Shek, C.C., see Lee, S. (24) 265
Maier, W., Lichtermann, D., Minges, J. and Heun, R. Simons, A.D., see Stuart, S. (24) 281
Personality traits in subjects at risk for unipolar major Solomon, R.A., see Da Roza Davis, J.M. (24) 177
depression: a family study perspective (24) 153 Starcevic, V., Kellner, R., Uhlenhuth, E.H. and Pathak, D.
Markowitz, J.C., Moran, M.E., Kocsis, J.H. and Frances, A.J. Panic disorder and hypochondriacal fears and beliefs (24)
Prevalence and comorbidity of dysthymic disorder among 73
psychiatric outpatients (24) 63 Steffert, B., see Birtchnell, J. (24) 165
Marks, M.N., Wieck, A., Checkley, S.A. and Kumar, R. Stevens, W.J., see Maes, M. (24) 127
Contribution of psychological and social factors to psy- Stuart, S., Simons, A.D., Thase, M.E. and Pilkonis, P.
chotic and non-psychotic relapse after childbirth in women Are personality assessments valid in acute major depres-
with previous histories of affective disorder (24) 253 sion? (24) 281
Masica, D.N., see Beasley, Jr., C.M. (24) 1 Subbakrishna, D.K., see Jagadeesh, H.N. (24) 291
Micciolo, R., see Tansella, M. (24) 117
Suy, E., see Maes, M. (24) 183
Minges, J., see Maier, W. (24) 153 Svrakic, D.M., Przybeck, T.R. and Cloninger, C.R.
Mitchell, P., see Parker, G. (24) 25 Mood states and personality traits (24) 217
Moran, M.E., see Markowitz, J.C. (24) 63
Mozley, P.D., see Amsterdam, J.D. (24) 43
Tansella, M. and Micciolo, R.
Mulder, R.T., see Wilson, D.A. (24) 11
Trends in the prescription of antidepressants in urban and
rural general practices (24) 117
Nieto, E., see Vieta, E. (24) 147
Tattersall, M.L. and Hallstrom, C.
Self-help and benzodiazepine withdrawal (24) 193
Parker, G., Boyce, P., Mitchell, P., Hadzi-Pavlovic, D., Wil-
Thase, M.E., see Stuart, S. (24) 281
helm, K., Hickie, I. and Brodaty, H.
Tyrer, P., see Holton, A. (24) 245
Comparison of clinician rated and family corroborative
witness data for depressed patients (24) 25
Parker, G., Roy, K., Hadzi-Pavlovic, D. and Pedic, F. Uhlenhuth, E.H., see Starcevic, V. (24) 73
Psychotic (delusional) depression: a meta-analysis of physi Uyttenbroeck, W., see Maes, M. (24) 183
cal treatments (24) 17
Pathak, D., see Starcevic, V. (24) 73 Van den Hoofdakker, R.H., see Beersma, D.G.M. (24) 101
Pedic, F., see Parker, G. (24) 17 Van Grootel, L., see Maes, M. (24) 183
Peeters, D., see Maes, M. (24) 127 Vieta, E., Nieto, E., Gast6, C. and Cirera, E.
Peselow, E.D., Fieve, R.R. and DiFiglia, C. Serious suicide attempts in affective patients (24) 147
Personality traits and response to desipramine (24) 209
Pilkonis, P., see Stuart, S. (24) 281 Wheadon, D.E., see Beasley, Jr., C.M. (24) 1
Plocka, M., see Rybakowski, J. (24) 87 Wieck, A., see Marks, M.N. (24) 253
Potvin, J.H., see Beasley, Jr., C.M. (24) 1 Wilhelm, K., see Parker, G. (24) 25
Pringuey, D., see Feuillade, P. (24) 135 Wilson, D.A., Mulder, R.T. and Joyce, P.R.
Przybeck, T.R., see Svrakic, D.M. (24) 217 Diurnal profiles of thyroid hormones are altered in de-
pression (24) 11
Quintana, J. Wing, Y.K., see Lee, S. (24) 265
Platelet serotonin and plasma tryptophan decreases in Winokur, G., see Coryell, W. (24) 93
Keyword Index
Acute phase proteins Benzodiazepine dependence
Visceral proteins; Psychoneuroimmunology; Depression; In- Benzodiazepine withdrawal; Self-help; TRANX (Tattersall,
flammation; Haptoglobin; Ceruloplasmin; Hemopexin; Retinol M.L. (24) 193)
binding protein; a,-Antitrypsin; Complement component C3C
(Maes, M. (24) 183) Benzodiazepines
Dependence; Outcome; Personality disorder (Holton, A. (24)
Affective disorders 245)
Attempted suicide; Depression (Vieta, E. (24) 147)
Benzodiazepine withdrawal
Agoraphobia Benzodiazepine dependence; Self-help; TRANX (Tattersall,
Panic disorder; Hypochondriasis; Death anxiety; Cognitive MLL. (24) 193)
orientation (Starcevic, V. (24) 73)
Bipolar disorder
Alcoholism Recurrent mania; Life course (Khanna, R. (24) 35)
Major depression; Family study (Coryell, W. (24) 93)
Bipolars
Antidepressant drugs Lithium prophylaxis; Interepisode mood; Normals (Bouman,
Psychotic depression; Antipsychotic drugs; Electroconvulsive T.K. (24) 199)
therapy; Meta-analysis (Parker, G. (24) 17)
Brown-Harris model
Depression; EEG sleep; Trimipramine (Feuillade, P. (24) 135) Provoking agent; Life stress; Italy (Lora, A. (24) 227)
Antidepressant prescribing Cell-mediated immunity
General practice; Population density; Seasonality (Tansella, Depression; Psychoneuroendocrinoimmunology; B cells; In-
M. (24) 117) flammation; Autoimmunity (Maes, M. (24) 127)
Antipsychotic drugs Ceruloplasmin
Psychotic depression; Antidepressant drugs; Electroconvulsive Acute phase proteins; Visceral proteins; Psychoneuroim-
therapy; Meta-analysis (Parker, G. (24) 17) munology; Depression; Inflammation; Haptoglobin;
Hemopexin; Retinol binding protein; a,-Antitrypsin; Comple-
a ,-Antitrypsin ment component C3C (Maes, M. (24) 183)
Acute phase proteins; Visceral proteins; Psychoneuroim-
munology; Depression; Inflammation; Haptoglobin; Cerulo- Chinese
plasmin; Hemopexin; Retinol binding protein; Complement Lithium; Folate (Lee, S. (24) 265)
component C3C (Maes, M. (24) 183)
Chinese medical students
Anxiety Depression; Coping activities; Coping strategies (Chan, D.W.
Depression; GHQ; SCL-90; Validity (Koeter, M.W.J. (24) (24) 109)
271)
Cognitive orientation
Attempted suicide Panic disorder; Agoraphobia; Hypochondriasis; Death anxiety
Affective disorders; Depression (Vieta, E. (24) 147) (Starcevic, V. (24) 73)
Autoimmunity Comorbidity
Depression; Psychoneuroendocrinoimmunology; B cells; In- Dysthymic disorder; Prevalence (Markowitz, J.C. (24) 63)
flammation; Cell-mediated immunity (Maes, M. (24) 127)
Complement component C3C
B cells Acute phase proteins; Visceral proteins; Psychoneuroim-
Depression; Psychoneuroendocrinoimmunology; Inflamma- munology; Depression; Inflammation; Haptoglobin; Cerulo-
tion; Autoimmunity; Cell-mediated immunity (Maes, M. (24) plasmin; Hemopexin; Retinol binding protein; a,-Antitrypsin
127) (Maes, M. (24) 183)
302
Coping activities DSM-III personality disorder; Desipramine; Treatment re-
Depression; Coping strategies; Chinese medical students sponse (Peselow, E.D. (24) 209)
(Chan, D.W. (24) 109)
Postpartum psychosis; Risk factors (Marks, M.N. (24) 253)
Coping strategies
Depression; Coping activities; Chinese medical students Anxiety; GHQ; SCL-90; Validity (Koeter, M.W.J. (24) 271)
(Chan, D.W. (24) 109)
Desipramine
Corroborative witnesses DSM-III personality disorder; Depression; Treatment re-
Depression; Inter-rater agreement (Parker, G. (24) 25) sponse (Peselow, E.D. (24) 209)
Cortisol Dexamethasone suppression test
Seasonal variation; Depression; Schizophrenia; Gender differ- Seasonal variation; Depression; Schizophrenia; Gender differ-
ence; Dexamethasone suppression test (Rybakowski, J. (24) ence; Cortisol (Rybakowski, J. (24) 87)
87)
Diurnal change
Death anxiety Depression; Free thyroxine index; Thyroxine (Wilson, D.A.
Panic disorder; Agoraphobia; Hypochondriasis; Cognitive ori- (24) 11)
entation (Starcevic, V. (24) 73)
Double blind study
Dependence Endogenous depression; Single ECT vs. thrice weekly ECT;
Benzodiazepines; Outcome; Personality disorder (Holton, A. Time dependent effects (Jagadeesh, H.N. (24) 291)
(24) 245)
DSM-III personality disorder
Depression Depression; Desipramine; Treatment response (Peselow, E.D.
Fluoxetine; Suicidality; Obsessive-compulsive disorder; Sero- (24) 209)
tonin (Beasley, Jr., C.M. (24) 1)
Dysthymic disorder
Prevalence; Comorbidity (Markowitz, J.C. (24) 63)
Diurnal change; Free thyroxine index; Thyroxine (Wilson,
D.A. (24) 11)
EEG sleep
Antidepressant drugs; Depression; Trimipramine (Feuillade,
Corroborative witnesses; Inter-rater agreement (Parker, G.
P. (24) 135)
(24) 25)
Electroconvulsive therapy
Seasonal variation; Schizophrenia; Gender difference; Corti-
Psychotic depression; Antidepressant drugs; Antipsychotic
sol; Dexamethasone suppression test (Rybakowski, J. (24) 87)
drugs; Meta-analysis (Parker, G. (24) 17)
Coping activities; Coping strategies; Chinese medical students
Endogenous depression
(Chan, D.W. (24) 109)
Platelet serotonin; Plasma tryptophan; Imipramine; Serotonin
(Quintana, J. (24) 55)
Psychoneuroendocrinoimmunology; B cells; Inflammation;
Autoimmunity; Cell-mediated immunity (Maes, M. (24) 127)
Single ECT vs. thrice weekly ECT; Double blind study; Time
dependent effects (Jagadeesh, H.N. (24) 291)
Antidepressant drugs; EEG sleep; Trimipramine (Feuillade,
P. (24) 135) Examination
Personality disorder; Major depressive disorder; Personality
Attempted suicide; Affective disorders (Vieta, E. (24) 147) disorder; Relapse (Stuart, S. (24) 281)
Relating; Questionnaire; Recovery (Birtchnell, J. (24) 165) Family study
Alcoholism; Major depression (Coryell, W. (24) 93)
5-HT, receptor; Sleep EEG; Slow wave sleep; REM latency
(Da Roza Davis, J.M. (24) 177) Premorbid personality; Unipolar depression; Neuroticism
(Maier, W. (24) 153)
Acute phase proteins; Visceral proteins; Psychoneuroim-
munology; Inflammation; Haptoglobin; Ceruloplasmin; Fluoxetine
Hemopexin; Retinol binding protein; a,-Antitrypsin; Comple- Suicidality; Obsessive-compulsive disorder; Depression; Sero-
ment component C3C (Maes, M. (24) 183) tonin (Beasley, Jr., C.M. (24) 1)
303
Folate lada. het: H
Lithium; Chinese (Lee, S. (24) 265) Single photon emission computed tomography; Major depres-
sion (Amsterdam, J.D. (24) 43)
Free thyroxine index
Depression; Diurnal change; Thyroxine (Wilson, D.A. (24) 11) Italy
Provoking agent; Life stress; Brown-Harris model (Lora, A.
Gender difference (24) 227)
Seasonal variation; Depression; Schizophrenia; Cortisol; Dex-
amethasone suppression test (Rybakowski, J. (24) 87) Life course
Bipolar disorder; Recurrent mania (Khanna, R. (24) 35)
General practice
Antidepressant prescribing; Population density; Seasonality Life stress
(Tansella, M. (24) 117) Provoking agent; Brown-Harris model; Italy (Lora, A. (24)
227)
GHQ
Anxiety; Depression; SCL-90; Validity (Koeter, M.W.J. (24) Light therapy
Seasonal depression; Ultraviolet (Lam, R.W. (24) 237)
271)
Lithium
Haptoglobin
Folate; Chinese (Lee, S. (24) 265)
Acute phase proteins; Visceral proteins; Psychoneuroim-
munology; Depression; Inflammation; Ceruloplasmin;
Lithium prophylaxis
Hemopexin; Retinol binding protein; a,-Antitrypsin; Comple-
Interepisode mood; Normals; Bipolars (Bouman, T.K. (24)
ment component C3C (Maes, M. (24) 183)
199)
Hemopexin
Major depression
Acute phase proteins; Visceral proteins; Psychoneuroim-
lodo-amphetamine; Single photon emission computed tomog-
munology; Depression; Inflammation; Haptoglobin; Cerulo-
raphy (Amsterdam, J.D. (24) 43)
plasmin; Retinol binding protein; a,-Antitrypsin; Comple-
ment component C3C (Maes, M. (24) 183)
Alcoholism; Family study (Coryell, W. (24) 93)
5-HT, receptor
Sleep; Non-REM sleep (Beersma, D.G.M. (24) 101)
Sleep EEG; Slow wave sleep; REM latency; Depression
(Da Roza Davis, J.M. (24) 177)
Major depressive disorder
Personality disorder; Personality disorder; Examination; Re-
Hypochondriasis
lapse (Stuart, S. (24) 281)
Panic disorder; Agoraphobia; Death anxiety; Cognitive orien-
tation (Starcevic, V. (24) 73)
Meta-analysis
Psychotic depression; Antidepressant drugs; Antipsychotic
Imipramine drugs; Electroconvulsive therapy (Parker, G. (24) 17)
Endogenous depression; Platelet serotonin; Plasma trypto-
phan; Serotonin (Quintana, J. (24) 55) Mood state
Personality trait (Svrakic, D.M. (24) 217)
Inflammation
Depression; Psychoneuroendocrinoimmunology; B cells; Au- Neuroticism
toimmunity; Cell-mediated immunity (Maes, M. (24) 127) Premorbid personality; Unipolar depression; Family study
(Maier, W. (24) 153)
Acute phase proteins; Visceral proteins; Psychoneuroim-
munology; Depression; Haptoglobin; Ceruloplasmin; Non-REM sleep
Hemopexin; Retinol binding protein; a,-Antitrypsin; Comple- Sleep; Major depression (Beersma, D.G.M. (24) 101)
ment component C3C (Maes, M. (24) 183)
Normals
Interepisode mood Lithium prophylaxis; Interepisode mood; Bipolars (Bouman,
Lithium prophylaxis; Normals; Bipolars (Bouman, T.K. (24) T.K. (24) 199)
199)
Ob ive pulsive disorder
Inter-rater agreement Fluoxetine; Suicidality; Depression; Serotonin (Beasley, Jr.,
Depression; Corroborative witnesses (Parker, G. (24) 25) C.M. (24) 1)
304
Outcome Questionnaire
Benzodiazepines; Dependence; Personality disorder (Holton, Depression; Relating; Recovery (Birtchnell, J. (24) 165)
A. (24) 245)
Recovery
Panic disorder Depression; Relating; Questionnaire (Birtchnell, J. (24) 165)
Agoraphobia; Hypochondriasis; Death anxiety; Cognitive ori-
entation (Starcevic, V. (24) 73) Recurrent mania
Bipolar disorder; Life course (Khanna, R. (24) 35)
Personality disorder
Benzodiazepines; Dependence; Outcome (i iolton, A. (24) 245) Relapse
Personality disorder; Major depressive disorder; Personality
Major depressive disorder; Personality disorder; Examination; disorder; Examination (Stuart, S. (24) 281)
Relapse (Stuart, S. (24) 281)
Relating
Personality disorder; Major depressive disorder; Examination; Depression; Questionnaire; Recovery (Birtchnell, J. (24) 165)
Relapse (Stuart, S. (24) 281)
REM latency
Personality trait 5-HT, receptor; Sleep EEG; Slow wave sleep; Depression
Mood state (Svrakic, D.M. (24) 217) (Da Roza Davis, J.M. (24) 177)
Plasma tryptophan Retinol binding protein
Endogenous depression; Platelet serotonin; Imipramine; Acute phase proteins; Visceral proteins; Psychoneuroim-
Serotonin (Quintana, J. (24) 55) munology; Depression; Inflammation; Haptoglobin; Cerulo-
plasmin; Hemopexin; a,-Antitrypsin; Complement compo-
Platelet serotonin nent C3C (Maes, M. (24) 183)
Endogenous depression; Plasma tryptophan; Imipramine;
Serotonin (Quintana, J. (24) 55) Risk factors
Postpartum psychosis; Depression (Marks, M.N. (24) 253)
Population density
Antidepressant prescribing; General practice; Seasonality Schizophrenia
(Tansella, M. (24) 117) Seasonal variation; Depression; Gender difference; Cortisol;
Dexamethasone suppression test (Rybakowski, J. (24) 87)
Postpartum psychosis
Depression; Risk factors (Marks, M.N. (24) 253) SCL-90
Anxiety; Depression; GHQ; Validity (Koeter, M.W.J. (24)
Premorbid personality 271)
Unipolar depression; Family study; Neuroticism (Maier, W.
(24) 153) Seasonal depression
Light therapy; Ultraviolet (Lam, R.W. (24) 237)
Prevalence
Dysthymic disorder; Comorbidity (Markowitz, J.C. (24) 63) Seasonality
Antidepressant prescribing; General practice; Population
Provoking agent density (Tansella, M. (24) 117)
Life stress; Brown-Harris model; Italy (Lora, A. (24) 227)
Seasonal variation
doort, 2 1 Depression; Schizophrenia; Gender difference; Cortisol; Dex-
oye T
Depression; B cells; Inflammation; Autoimmunity; Cell-medi- amethasone suppression test (Rybakowski, J. (24) 87)
ated immunity (Maes, M. (24) 127)
Self-help
Psych i logy Benzodiazepine withdrawal; Benzodiazepine dependence;
Acute phase proteins; Visceral proteins; Depression; Inflam- TRANX (Tattersall, M.L. (24) 193)
mation; Haptoglobin; Ceruloplasmin; Hemopexin; Retinol
binding protein; a,-Antitrypsin; Complement component C3C Serotonin
(Maes, M. (24) 183) Fluoxetine; Suicidality; Obsessive-compulsive disorder; De-
pression (Beasley, Jr., C.M. (24) 1)
Psychotic depression
Antidepressant drugs; Antipsychotic drugs; Electroconvulsive Endogenous depression; Platelet serotonin; Plasma trypto-
therapy; Meta-analysis (Parker, G. (24) 17) phan; Imipramine (Quintana, J. (24) 55)
Single ECT vs. thrice weekly ECT TRANX
Endogenous depression; Double blind study; Time dependent Benzodiazepine withdrawal; Benzodiazepine dependence;
effects (Jagadeesh, H.N. (24) 291) Self-help (Tattersall, M.L. (24) 193)
Single photon emission computed tomography
Treatment response
lodo-amphetamine; Major depression (Amsterdam, J.D. (24)
DSM-III personality disorder; Depression; Desipramine
43)
(Peselow, E.D. (24) 209)
Sleep
Major depression; Non-REM sleep (Beersma, D.G.M. (24) Trimipramine
101) Antidepressant drugs; Depression; EEG sleep (Feuillade, P.
(24) 135)
Sleep EEG
5-HT, receptor; Slow wave sleep; REM latency; Depression Ultraviolet
(Da Roza Davis, J.M. (24) 177) Seasonal depression; Light therapy (Lam, R.W. (24) 237)
Slow wave sleep
5-HT, receptor; Sleep EEG; REM latency; Depression Unipolar depression
(Da Roza Davis, J.M. (24) 177) Premorbid personality; Family study; Neuroticism (Maier, W.
(24) 153)
Suicidality
Fluoxetine; Obsessive-compulsive disorder; Depression; Sero- Validity
tonin (Beasley, Jr., C.M. (24) 1) Anxiety; Depression; GHQ; SCL-90 (Koeter, M.W.J. (24) 271)
Thyroxine
Visceral proteins
Depression; Diurnal change; Free thyroxine index (Wilson,
Acute phase proteins; Psychoneuroimmunology; Depression;
D.A. (24) 11)
Inflammation; Haptoglobin; Ceruloplasmin; Hemopexin;
Retinol binding protein; a,-Antitrypsin; Complement compo-
Time dependent effects
nent C3C (Maes, M. (24) 183)
Endogenous depression; Single ECT vs. thrice weekly ECT;
Double blind study (Jagadeesh, H.N. (24) 291)